Chrome Extension
WeChat Mini Program
Use on ChatGLM

Efficacy and Safety of Alemtuzumab Versus Fingolimod in RRMS after Natalizumab Cessation

Journal of neurology(2018)

Cited 21|Views66
No score
Key words
Alemtuzumab,Natalizumab,Fingolimod,Remitting-relapsing multiple sclerosis,Progressive multifocal leukoencephalopathy,Immunomodulatory therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined